Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation

American Journal of Hematology

Volumn 90, Issue 1, 2015, Pages E9-E16

  Lv, Meng ^a   Zhao, Xiao Su ^a   Hu, Yue ^a,b   Chang, Ying Jun ^a   Zhao, Xiang Yu ^a   Kong, Yuan ^a   Zhang, Xiao Hui ^a   Xu, Lan Ping ^a   Liu, Kai Yan ^a   Huang, Xiao Jun ^a,b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Tsinghua University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRANULOCYTE; HUMAN; IMMUNOLOGICAL TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROMYELOCYTE; RELAPSE; SUPPRESSOR CELL; ADOLESCENT; ALLOTRANSPLANTATION; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CLINICAL TRIAL; DONOR; GRAFT VS HOST DISEASE; GRANULOCYTE PRECURSOR; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; LEUKEMIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROCEDURES; STEM CELL MOBILIZATION; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE PRECURSOR CELLS; HAPLOTYPES; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; LEUKEMIA; MALE; MIDDLE AGED; MONOCYTES; MULTIVARIATE ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84919681261     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23865     Document Type: Article

References (40)

1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
2. Tadmor T, Attias D, Polliack A. Myeloid-derived suppressor cells--Their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br J Haematol 2011;153:557-567.
3. Peranzoni E, Zilio S, Marigo I, et al. Myeloid-derived suppressor cell heterogeneity and subset definition. Current opinion in immunology 2010;22:238-244.
4. Highfill SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010;116:5738-5747.
5. Wang D, Yu Y, Haarberg K, et al. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 2013;19:692-702.
6. Mougiakakos D, Jitschin R, von Bahr L, et al. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 2013;27:377-388.
7. Wang Y, Chang YJ, Xu LP, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood 2014;124:843-850.
8. Huang XJ, Zhu HH, Chang YJ, et al. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 2012;119:5584-5590.
9. Wang Y, Liu DH, Liu KY, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 2013;119:978-985.
10. Chang YJ, Huang XJ. Haploidentical bone marrow transplantation without T-cell depletion. Semin Oncol 2012;39:653-663.
11. Chang YJ, Huang XJ. Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: A comprehensive review. Clin Transplant 2011;25:13-23.
12. Chang YJ, Huang XJ. Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts. Curr Opin Hematol 2012;19:454-461.
13. Huang XJ, Chang YJ. Unmanipulated HLA-mismatched/haploidentical blood and marrow hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17:197-204.
14. Jun HX, Jun CY, Yu ZX. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 2004;89:1517-1524.
15. Jun HX, Jun CY, Yu ZX. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica 2005;90:715-716.
16. Rutella S, Zavala F, Danese S, et al. Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance. J Immunol 2005;175:7085-7091.
17. Zhao XY, Xu LL, Lu SY, et al. IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Eur J Immunol 2011;41:514-526.
18. Zhao XY, Lv M, Xu LL, et al. Donor Th17 cells and IL-21 may contribute to the development of chronic graft-versus-host disease after allogeneic transplantation. Eur J Immunol 2013;43:838-850.
19. Xu LP, Liu KY, Liu DH, et al. The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis. Bone Marrow Transplant 2010;45:985-992.
20. Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: Current status and future perspectives. Blood 2011;118:6006-6017.
21. Shojaei F, Wu X, Zhong C, et al. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007;450:825-831.
22. Xiao-Jun H, Lan-Ping X, Kai-Yan L, et al. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies. Clin Cancer Res 2009;15:4777-4783.
23. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-828.
24. Martin PJ. Study design and endpoints in graft-versus-host disease. Best Practice Res Clin Haematol 2008;21:357-372.
25. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-217.
26. Mougiakakos D, Jitschin R, von Bahr L, et al. Immunosuppressive CD14(+)HLA-DR(low/neg) IDO(+) myeloid cells in patients following allogeneic hematopoietic stem cell transplantation. Leukemia 2013;27:377-388.
27. Luyckx A, Schouppe E, Rutgeerts O, et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clinical Immunol 2012;143:83-87.
28. Solito S, Falisi E, Diaz-Montero CM, et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011;118:2254-2265.
29. Zhao XY, Chang YJ, Xu LP, et al. Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors. Bone Marrow Transplant 2009;44:721-728.
30. Lu SY, Liu KY, Liu DH, et al. High frequencies of CD62L(+) naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic Haematopoietic stem cell transplantation. Clin Exp Immunol 2011;165:264-277.
31. Aranha FJ, Vigorito AC, De Sousa CA, et al. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation. Haematologica 2002;87:219-220.
32. Arpinati M, Chirumbolo G, Saunthararajah Y, et al. Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. Biol Blood Marrow Transplant 2007;13:228-234.
33. Vendramin A, Gimondi S, Bermema A, et al. The graft monocytic myeloid derived suppressor cells content predicts the risk of acute graft versus host disease after allogeneic transplantation of granulocyte colony-stimulating factor mobilized peripheral blood stem cells. Biol Blood Marrow Transplant, 2014 Sep 20. pii: S1083-8791(14)00566-7. doi: 10.1016/j.bbmt.2014.09.011. [Epub ahead of print].
34. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: An update. Blood 2010;115:3861-3868.
35. Le Blanc K, Jitschin R, Mougiakakos D. Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation: A double-edged sword? Oncoimmunology 2013;2:e25009.
36. Hoechst B, Gamrekelashvili J, Manns MP, et al. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells. Blood 2011;117:6532-6541.
37. Arcese W, De Angelis G, Cerretti R. Granulocyte-mobilized bone marrow. Current Opin Hematol 2012;19:448-453.
38. Di Bartolomeo P, Santarone S, De Angelis G, et al. Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood 2013;121:849-857.
39. Ling YW, Liu QF, Liu C, et al. [Effect of granulocyte colony stimulating factor on myeloid-derived suppressor cells in the bone marrow and peripheral blood: a preliminary study]. Nan fang yi ke da xue xue bao 2011;31:1190-1192.
40. McDermott SP, Eppert K, Lechman ER, et al. Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 2010;116:193-200.